The Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors in Severe Non-proliferative Diabetic Retinopathy
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Purpose: To evaluate the effects of angiotensin-converting enzyme inhibitors (ACE-I) in retarding progression of severe non-proliferative diabetic retinopathy (NPDR) in normotensive type 2 diabetic patients. Methods: This was a retrospective case control study of 128 patients with normotensive type 2 diabetes with lower than +1 dipstick proteinuria and severe NPDR who were classified into either an ACE-I treated group (Enalapril maleate 10 mg, n=12 , Ramipril 5 mg, n=17) or an ACE-I untreated group (n=99). Medical records were reviewed for endpoints of (a) occurrence of proliferative diabetic retinopathy (PDR) or macular edema (ME) for which laser phototherapy was necessary or (b) development of proteinuria of higher than +1 level requiring medication of ACE-I. Results: From the total of 128 patients, there were 29 ACE-I treated patients and 99 ACE-I untreated patients. There were no differences in the average age, duration of diabetes, body mass indices, blood pressure and levels of hyperglycemia or HbA1C between the two groups. Blood pressure and HbA1C levels in both groups remained unchanged during the study. The mean follow-up period was 41.6 months. In the ACE-I group, 6 patients progressed to PDR, 5 to ME and 6 developed proteinuria of greater than +1 over the follow-up period. In the control group, 30 patients progressed to PDR, 6 to ME and 9 developed proteinuria of greater than +1 over the follow-up period. Conclusions: Small doses of ACE-I did not yield any beneficial effects in retarding the progression of severe NPDR.
참고문헌 (22)
- Porta M, "Current approaches and perspectives in the medical treatment of diabetic retinopathy", 103, pp.167~177 (2004)
- Cohen RA, "Determinants of retinopathy progression in type 1 diabetes mellitus", 107, pp.45~51 (1999)
- Klein R, "Vision disorders in diabetes", pp.14~ (1995), Washington DC: NIH Publication
- Aiello L, "Diabetic eye disease", 25, pp.271~292 (1996)
- Funatsu H, "Pathogenesis of diabetic retinopathy and the renin-angiotensine system", 23, pp.495~501 (2003)
- Danser AHJ, "and immunoreactive renin in vitreous fluid fromeyes with and without diabetic retinopathy", pp.160~7
- Danser AHJ, "Angiotensin levels in the eye", 35, pp.1008~18 (1994)
- Funatsu H, "Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy", 86, pp.311~315 (2002)
- Funatsu H, "Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders", 133, pp.537~543 (2002)
- Wagner J, "Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system", 80, pp.159~163 (1996)
- Park WC, "Relationship of diabetic retinopathy and serum angiotensin-converting enzyme", 29, pp.847~50 (1988)
- Parving HH, "Effect of antihypertnensive treatment on blood-retinal permeability to fluorescein in hypertnesive type 1(insulin-dependent)diabetes patients with background retinopathy", 32, pp.440~4 (1989)
- Le Noble FA, "Angiotensin II stimulates angiogenesis in the chorio- allantoic membrane of the chick embryo", 195, pp.305~6 (1991)
- Chaturvedi N, "Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes", 351, pp.28~31 (1998)
- Early Treatment Diabetic Retinopathy Study, "Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Arlie House Classification", pp.786~806
- Heum C, "Diabetes mellitus and the eye, 1st ed", pp.145~149 (2000), Seoul national university book
- Aiello LP, "Systemic considerations in the management of diabetic retinopathy", 132, pp.760~776 (2001)
- The Diabetes Control, "Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy", 342, pp.381~389 (2000)
- Jackson E, "Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy", 24, pp.99~103 (1992)
- Rachmani R, "Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes", 11, pp.48~50 (2000)
- Pradhan R, "Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive type 2 diabetic patients.A pilot study", 16, pp.377~381 (2002)
- Orchard TJ, "Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus", 157, pp.1851~1856 (1997)